Blog & News
Follow along for updates and insights on how we’re helping to drive the future of healthcare innovation.
Linking Real-World Clinical Data with Medical Device Data to Demonstrate Device Value
Real-World Data in the Medical Device Market Many life sciences organizations are focused on harnessing real-world data (RWD) capabilities to inform every part of the drug development product life cycle. The same types of RWD can, and should, be applied to innovation...
Linking Real-World Clinical Data with Medical Device Data to Demonstrate Device Value
Real-World Data in the Medical Device Market Many life sciences organizations are focused on harnessing real-world data (RWD) capabilities to inform every part of the drug development product life cycle. The same types of RWD can, and should, be applied to innovation...
Social Determinants of Health: Generating Accurate Clinical Insights Using Real-World Data
Recent innovations in healthcare analytics and patient-oriented AI demonstrate the power of leveraging real world data (RWD) to generate ecologically valid actionable insights for life sciences companies to improve patient lives and streamline new therapeutic...
Five Strategies To Boost Clinical Trial Diversity
Five Natural Language Processing Subtasks that Large Language Models Can Perform to Improve Healthcare
In late 2022, the technology world was turned upside down as OpenAI released ChatGPT, its new artificial intelligence (AI) model. Unlike most previous natural language processing (NLP) models, this model contained billions of parameters, was trained on a corpus of...
ISPOR Europe 2023: OMNY Health Real-World Data Platform Powering HEOR
HEOR at the Nexus of Policy and Science OMNY Health believes in the importance of a truly transparent, secure, and connected real-world data (RWD) ecosystem to accelerate life-changing care and treatment innovation between providers, patients, and life science...
Practical Applications of FDA’s Guidelines on Use of Real-World Data and Real-World Evidence to Support Regulatory Decision-Making for Drug and Biological Products
On August 31, 2023, the U.S. Food and Drug Administration (FDA) released “Considerations for the Use of Real-World Data and Real-World Evidence to Support Regulatory Decision-Making for Drug and Biological Products: Guidance for Industry.”[1] FDA issued this guidance...
OMNY Health and Datavant Announce Alliance to Accelerate Delivery of Real-World Data Between Healthcare Stakeholders to Enhance Clinical Research and Drug Development
– Collaboration enables provider organizations to deliver de-identified, longitudinal data sets to life science companies and other trial sponsors – – Real-world data offers unique insights in clinical research as drug developers focus on increasing equity in...